Investor · New York, NY

Matthew Tomich

Open Matthew in the network graph →

Filings

11

SEC Form D

Connections

126

co-filers

Capital

$550K

across filings

Active

Aug 2017

to Jun 2023

Most-connected co-filers (126)

Christopher Brandt · Manhattan, KS6 shared Randall Tosh · Olathe, KS5 shared Fred Ausubel · Allston, MA4 shared David Heath · Dallas, TX4 shared Matthew Davis · Purcellville, VA4 shared Ronald T. Lemay · Kansas City, MO4 shared Lauren Smith · Nashville, TN4 shared Jason Bergsman · SAN FRANCISCO, CA4 shared W. C. Mccollum · Los Angeles, CA4 shared Rodney Rogers · Alexandria, VA4 shared Peter Feld · New York, NY4 shared Michael P. Byrne · Boston, MA4 shared Kweli Washington · New York, NY4 shared Rockwell Hopkins · Dallas, TX4 shared Ronald Heffernan · Sandy, UT4 shared Ursula Newman · London, United Kingdom4 shared Philip L. Harrison · Atlanta, GA4 shared Cory Brown · Nashville, TN4 shared Thomas G. Scriven · Golden, CO4 shared Arthurs L. D'Arcy · Toronto, Ontario, Canada4 shared Mike Kerns · Playa Vista, CA4 shared Jesse S. Jacobs · Playa Vista, CA4 shared Gerald Ford · Dallas, TX4 shared Eric Davidson · Emeryville, CA4 shared

Recent filings (11)

ADIAL PHARMACEUTICALS, INC.Jun 2023 · 26 co-filers$3.1M ADIAL PHARMACEUTICALS, INC.Mar 2023 · 26 co-filers$62K Phoreus Biotechnology, Inc.May 2022 · 17 co-filers$3.0M Phoreus Biotechnology, Inc.May 2022 · 17 co-filers$3.0M Phoreus Biotechnology, Inc.May 2020 · 13 co-filers$2.0M University of Phoenix, Inc.Apr 2020 · 65 co-filers$127K Phoreus Biotechnology, Inc.Dec 2019 · 14 co-filers$1.1M University of Phoenix, Inc.Jun 2018 · 55 co-filers$385K ADIAL PHARMACEUTICALS, INC.Jun 2018 · 23 co-filers$325K University of Phoenix, Inc.Sep 2017 · 35 co-filers University of Phoenix, Inc.Sep 2017 · 35 co-filers ADial Pharmaceuticals, L.L.C.Aug 2017 · 15 co-filers$40K

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Matthew in the interactive graph →